Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Factors and Biomarkers for Post-tuberculosis Lung Damage in a Chinese Cohort: Protocol for a Prospective Observational Study

NCT05426720 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT05426720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05426720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Factors and Biomarkers for Post-tuberculosis Lung Damage in a Chinese Cohort: Protocol for a Prospective Observational Study
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2022
Completion date
December 31, 2027
Enrollment
400 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary tb